5Maia FF, AraujoLR. Efficacy of Confinous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecog- nized hypoglycemia in type I diabetic patients. Diabetes ResClin Pract 2007 ;75:30 - 34.
5Wenthoh IME, Kulik W, Michels RP, et al. Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia ,2008,51 : 183-190.
6Marfella R,Barbieri M, Grella R,et al. Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations. J Diabetes Complications ,2009, [ Epub ahead of print].
7Heine RJ, Van Gaal LF, Johns D, et al. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes. Ann Intern Med,2005 ,143 :559-569.
8Kohnert KD, Auqstein P, Zander E, et al. Glycemic variability strongly correlates with postprandial β-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglyeemie agents. Diabetes Care,2009, [ Epub ahead of print].
9Lachin JM,Genuth S, Nathan DM, et al. Effect of glycemic exposure on the risk of microvascular complications in the Diabetes Control and Complications Trial-Revisited. Diabetes,2008,57:995-1001.
10Sassa M, Yamada Y, Hosokawa M, et al. Glycemic instability in type 1 diabetic patients:Possible role of ketosis or ketoacidosis at onset of diabetes. Diabetes Res Clin Pract,2008,81 : 190-195.
